Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial

作者：Chao Sun, Yunpeng Liu, Peng Zhang, Xu Wang, Yinghui Xu, Xingyu Lin, Xiaobo Ma, Ye Guo, Shi Qiu, Guoguang Shao, Zhiguang Yang, Kewei Ma · 发表于：Journal of Cancer Research and Clinical Oncology · 年份：2022 · DOI：10.1007/s00432-021-03896-w · 被引用次数：39 · 研究领域：Lung Cancer Diagnosis and Treatment、Cancer Immunotherapy and Biomarkers、Radiomics and Machine Learning in Medical Imaging